QUOTE AND NEWS
FiercePharma  6 hrs ago  Comment 
Whistleblowers alleging Eli Lilly ran a "multi-tiered kickback scheme" by offering nursing services in exchange for scripts will have a chance to rework their complaint after a judge tossed the case.
FierceBiotech  8 hrs ago  Comment 
Steven Paul, M.D., has taken over as CEO of Karuna Pharmaceuticals. The appointment puts the Sage and Voyager co-founder in charge of advancing a muscarinic agonist he worked on at Eli Lilly in the 1990s.
MedPage Today  Aug 13  Comment 
(MedPage Today) -- Similar rates of remission with continued amisulpride and switch to olanzapine
FiercePharma  Aug 10  Comment 
A couple of drugmakers are celebrating this week after favorable decisions from England’s cost watchdog. The National Institute for Health and Care Excellence has recommended both Eli Lilly’s Taltz and Pfizer’s Besponsa.
Motley Fool  Aug 10  Comment 
Here's how this company became a biopharma giant, and what could be in store next for investors.
Market Intelligence Center  Aug 7  Comment 
A trader took a big position in Eli Lilly and Co. (LLY) Tuesday morning. So far, 10,144 contracts of the... Read More > The post Trader make big bet on Eli Lilly appeared first on InvestorsObserver.
Yahoo  Aug 5  Comment 
Earnings is providing a much-needed boost to the biotech sector last week, with big-name companies like Eli Lilly And Co (NYSE: LLY ) and Pfizer Inc. (NYSE: PFE ) all trading at fresh 52-week highs in ...
FiercePharma  Aug 3  Comment 
Little more than a week after investors applauded Eli Lilly’s plan to spin off its animal health unit, Elanco, the company has filed its IPO documents for all to see. What's in the fine print? A company with $3 billion in 2017 sales and plenty...




Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki